datalabs-logo

  • Ask Inc42
  • My Feed
  • Companies
  • Investors
  • People
  • Funding Rounds
  • Acquisitions
  • Research Reports
  • Industries
  • Locations
ImmunoACT-logo
ImmunoACT
  1. ImmunoACT

ImmunoACT-logoImmunoACT-logo
ImmunoACT

ImmunoACT - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Private
IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED
Private
IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED
2018
2018

Founded in 2018, ImmunoACT operates in Health Tech offering gene-modified cell therapies, specifically CAR-T cell therapy for treating certain B-cell malignancies. The company was spun out from IIT-Bo...

Funding stage:

Corporate Round

Last funding:

30/05/2023

Total funding:

$17.18 Mn+

Revenue:

₹67.6 Cr+ (FY25)
Prev. FY

Investors

Employee count:

190

Last 90d

190

Last 90d

Web traffic:

14.02K

14.02K

Last 30d

Last 30d

Glassdoor Rating:

ImmunoACT: Financial Breakdown

Decoding financial health metrics of ImmunoACT

  • total_revenue_logo
    Total Revenue
    ₹67.6 Cr
    509%

    Prev. FY

  • total_expenses_logo
    Total Expenses
    ₹62.1 Cr
    138%

    Prev. FY

  • profit_after_tax_logo
    Profit After Tax
    ₹10.2 Cr
    167%

    Prev. FY

  • total_assets_logo
    Total Assets
    ₹134.3 Cr
    17%

    Prev. FY

  • net_profit_margin_logo
    Net Profit Margin
    15.1%
    111%

    Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of ImmunoACT

Yes. In FY25, ImmunoACT reported a profit after tax of ₹10.2 Cr, making it profitable.

ImmunoACT's revenue grew 509.7% year-on-year, from ₹11.1 Cr in FY24 to ₹67.6 Cr in FY25.

ImmunoACT's estimated EBITDA for FY25 was ₹12.3 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.

In FY25, ImmunoACT posted revenue of ₹67.6 Cr (up 509.7% YoY) and a profit after tax of ₹10.2 Cr. Explore the full financials of ImmunoACT here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

  • Data Disclaimer
  • Data Updation Policy
  • Claim/Correct Profile
MY FEEDDISCOVERRESEARCH